Janus Henderson Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121M | Buy |
|
|||||
|
2025
Q1 | $111M | Buy |
|
|||||
|
2024
Q4 | $109M | Buy |
|
|||||
|
2024
Q3 | $101M | Buy |
|
|||||
|
2024
Q2 | $85M | Buy |
|
|||||
|
2024
Q1 | $73.7M | Sell |
|
|||||
|
2023
Q4 | $95.9M | Buy |
|
|||||
|
2023
Q3 | $80.4M | Sell |
|
|||||
|
2023
Q2 | $96.9M | Buy |
|
|||||
|
2023
Q1 | $92.7M | Buy |
|
|||||
|
2022
Q4 | $83.9M | Sell |
|
|||||
|
2022
Q3 | $217M | Buy |
|
|||||
|
2022
Q2 | $124M | Buy |
|
|||||
|
2022
Q1 | $156M | Sell |
|
|||||
|
2021
Q4 | $223M | Sell |
|
|||||
|
2021
Q3 | $204M | Buy |
|
|||||
|
2021
Q2 | $189M | Buy |
|
|||||
|
2021
Q1 | $192M | Sell |
|
|||||
|
2020
Q4 | $160M | Buy |
|
|||||
|
2020
Q3 | $153M | Buy |
|
|||||
|
2020
Q2 | $180M | Buy |
|
|||||
|
2020
Q1 | $116M | Sell |
|
|||||
|
2019
Q4 | $190M | Buy |
|
|||||
|
2019
Q3 | $156M | Buy |
|
|||||
|
2019
Q2 | $176M | Buy |
|
|||||
|
2019
Q1 | $174M | Buy |
|
|||||
|
2018
Q4 | $134M | Buy |
|
|||||
|
2018
Q3 | $247M | Sell |
|
|||||
|
2018
Q2 | $192M | Buy |
|
|||||
|
2018
Q1 | $144M | Sell |
|
|||||
|
2017
Q4 | $125M | Buy |
|
|||||
|
2017
Q3 | $103M | Buy |
|
|||||
|
2017
Q2 | $72.3M | Buy |
|